Industry awaits the final revision of USP General Chapter and the impact it will have on the evaluation of sterile product package integrity. A proposed revision of the United States Pharmacopeia (USP ...
Revisions to USP General Chapter may impact evaluation of sterile product package integrity. A proposed revision of the United States Pharmacopeia (USP) General Chapter <1207>, Sterile Product Package ...
At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback